blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1711512

EP1711512 - PROCESS FOR PURIFYING PROTEINS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  24.10.2014
Database last updated on 03.10.2024
Most recent event   Tooltip16.01.2015Lapse of the patent in a contracting state
New state(s): CH, LI
published on 18.02.2015  [2015/08]
Applicant(s)For all designated states
AMGEN INC.
One Amgen Center Drive
Thousand Oaks, CA 91320 / US
[2006/42]
Inventor(s)01 / SENCZUK, Anna
19110 Stone Avenue North
Shoreline, WA 98133 / US
02 / KLINKE, Ralph
23841 SE 30th Street
Sammamish, WA 98075 / US
 [2006/42]
Representative(s)Care, Alison, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2014/03]Care, Alison, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Former [2006/42]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date04778787.421.07.2004
[2006/42]
WO2004US23434
Priority number, dateUS20040540587P30.01.2004         Original published format: US 540587 P
[2006/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005075498
Date:18.08.2005
Language:EN
[2005/33]
Type: A1 Application with search report 
No.:EP1711512
Date:18.10.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 18.08.2005 takes the place of the publication of the European patent application.
[2006/42]
Type: B1 Patent specification 
No.:EP1711512
Date:11.01.2012
Language:EN
[2012/02]
Search report(s)International search report - published on:EP18.08.2005
ClassificationIPC:C07K1/20
[2006/42]
CPC:
C07K1/20 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/42]
Extension statesAL25.08.2006
HR25.08.2006
LT25.08.2006
LV25.08.2006
MK25.08.2006
TitleGerman:VERFAHREN ZUR REINIGUNG VON PROTEINEN[2006/42]
English:PROCESS FOR PURIFYING PROTEINS[2006/42]
French:PROCEDE DESTINE A PURIFIER DES PROTEINES[2006/42]
Entry into regional phase25.08.2006National basic fee paid 
25.08.2006Designation fee(s) paid 
25.08.2006Examination fee paid 
Examination procedure30.11.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.08.2006Examination requested  [2006/42]
25.10.2007Despatch of a communication from the examining division (Time limit: M06)
18.04.2008Reply to a communication from the examining division
30.07.2009Despatch of a communication from the examining division (Time limit: M06)
05.02.2010Reply to a communication from the examining division
18.08.2011Communication of intention to grant the patent
18.11.2011Fee for grant paid
18.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.10.2007
Opposition(s)Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department
Björkgatan 30
751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Vanhalst, Koen
De Clercq & Partners cvba E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft mbB Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Bublak, Wolfgang, et al, et al
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
 [N/P]
Former [2014/18]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Vanhalst, Koen
De Clercq & Partners cvba E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft mbB Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Bublak, Wolfgang, et al, et al
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Former [2014/11]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Vanhalst, Koen
De Clercq & Partners cvba E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Bublak, Wolfgang, et al, et al
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Former [2013/52]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Vanhalst, Koen
De Clercq & Partners cvba E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Friede, Thomas, et al, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
Former [2013/47]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
De Clercq & Partners
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Friede, Thomas, et al, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
Former [2013/27]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Ma, Saufung, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Campabadal i Monfà, Gemma
Campabadal Patents bvba Koningin Astridlaan 33
9100 Sint-Niklaas / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Friede, Thomas, et al, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
Former [2013/26]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Campabadal i Monfà, Gemma
Campabadal Patents bvba Koningin Astridlaan 33
9100 Sint-Niklaas / BE
 04  11.10.2012  22.10.2012  ADMISSIBLE
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Friede, Thomas, et al, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
Former [2012/47]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Sant, David Paul, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012  16.10.2012  ADMISSIBLE
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012  17.10.2012  ADMISSIBLE
Lammert, Reinhild
Am Gönnabach 13
07751 Krippendorf Stadt Jena / DE
Opponent's representative
Campabadal i Monfà, Gemma
Campabadal Patents bvba Koningin Astridlaan 33
9100 Sint-Niklaas / BE
 04  11.10.2012   
BARDEHLE PAGENBERG Partnerschaft Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Opponent's representative
Friede, Thomas, et al, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
Former [2012/46]
Opponent(s)01  11.09.2012  19.09.2012  ADMISSIBLE
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Sant, David Paul, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
 02  10.10.2012   
GE Healthcare Bio-Sciences AB
Patent Department Björkgatan 30
SE-751 84 Uppsala / SE
Opponent's representative
Kilander, Ebba Annika, et al, et al
GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30
751 84 Uppsala / SE
 03  11.10.2012   
Amgen, Inc
One Amgen Center Drive
Thousand Oaks CA 91320 / US
Opponent's representative
Campabadal i Monfà, Gemma
Campabadal Patents bvba Koningin Astridlaan 33
9100 Sint-Niklaas / BE
Former [2012/42]
Opponent(s)01  11.09.2012   
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
Opponent's representative
Sant, David Paul, et al, et al
Taylor Wessing LLP
5 New Street Square
London EC4A 3TW / GB
15.11.2012Invitation to proprietor to file observations on the notice of opposition
25.06.2013Reply of patent proprietor to notice(s) of opposition
27.11.2013Cancellation of oral proceeding that was planned for 19.02.2014
19.02.2014Date of oral proceedings
21.05.2014Date of oral proceedings
21.05.2014Legal effect of revocation of patent [2014/48]
07.07.2014Despatch of minutes of oral proceedings
07.07.2014Despatch of communication that the patent will be revoked
Fees paidRenewal fee
14.08.2006Renewal fee patent year 03
13.07.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
10.07.2009Renewal fee patent year 06
14.07.2010Renewal fee patent year 07
12.07.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.07.2004
AT11.01.2012
BE11.01.2012
CH11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LI11.01.2012
NL11.01.2012
PL11.01.2012
RO11.01.2012
SE11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
IE21.07.2012
LU21.07.2012
MC31.07.2012
[2015/08]
Former [2014/34]HU21.07.2004
AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
RO11.01.2012
SE11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
IE21.07.2012
LU21.07.2012
MC31.07.2012
Former [2014/27]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
RO11.01.2012
SE11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
IE21.07.2012
LU21.07.2012
MC31.07.2012
Former [2014/21]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
RO11.01.2012
SE11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
IE21.07.2012
MC31.07.2012
Former [2013/33]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
RO11.01.2012
SE11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
IE21.07.2012
MC31.07.2012
Former [2012/41]BE11.01.2012
CY11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
Former [2012/37]BE11.01.2012
FI11.01.2012
NL11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
PT11.05.2012
Former [2012/36]BE11.01.2012
NL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
Former [2012/35]BE11.01.2012
NL11.01.2012
SI11.01.2012
BG11.04.2012
Former [2012/33]BE11.01.2012
SI11.01.2012
Former [2012/25]SI11.01.2012
Cited inInternational search[XY]US5231178  (HOLTZ GREGORY C [US], et al) [X] 1,4,5,7,13,16 * columns 11-13, 26-27, 32 * [Y] 3,8,10-12,15,18,19;
 [XY]US5395856  (HAASE FERDINAND C [US]) [X] 1,2,4-7,9,13,14,16,17 * column 10; example 8 *[Y] 3,8,10-12,15,18,19;
 [XY]US5928915  (WARNER THOMAS G [US], et al) [X] 1,2,4-7,9,13,14,16,17 * column 23 - column 24; example 1 * [Y] 3,8,10-12,15,18,19
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.